MEDILABO RFP
MEDILABO RFP
Industry:
Health Care Medical Product Research
Founded:
2018-08-10
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.medilaborfp.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Wordpress Plugins Nginx
Official Site Inspections
http://www.medilaborfp.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "medilabo RFP"
Medilabo RFP, Inc. | LinkedIn
Medilabo RFP, Inc., headquartered in Japan with a US office in Boston, is a clinical-stage biopharmaceutical company focused on developing repurposed small molecules-based …See details»
MEDILABO RFP, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MEDILABO RFP, INC. of KYOTO, KYOTO. Get the latest business insights from Dun & Bradstreet.See details»
medilabo RFP - Crunchbase Company Profile & Funding
Medilab RFP focuses on designing and developing innovative medicine for neurodegenerative disorders. There is no recent news or activity for this profile. View contacts for medilabo RFP …See details»
medilabo RFP, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore medilabo RFP, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Nervous System Diseases, Endocrinology and ...See details»
medilabo
ML1808 is an intranasal anti-Alzheimer drug. It suppresses not only Aβ oligomer but also tau oligomer and oxifative stress by using 2 active ingredients: rifampicin(RFP) and compound X. …See details»
Medilabo RFP, Inc. | LinkedIn
Medilabo RFP, Inc. | 19 followers on LinkedIn. A company supported by concrete science and innovative thinking for a healthier aging society | Medilabo RFP, Inc., headquartered in Japan …See details»
Medilabo RFP, Inc. Overview | SignalHire Company Profile
Medilabo RFP, Inc., headquartered in Japan with a US office in Boston, is a clinical-stage biopharmaceutical company focused on developing repurposed small molecules-based …See details»
Medilabo Rfp, Inc. - govtribe.com
MedilaboRFP is a clinical stage biotech company focused on developing repurposed small molecules based treatments to prevent and treat neurodegenerative dementia of all types. …See details»
Medilabo US, Inc. Details - govtribe.com
MedilaboRFP is a clinical stage biotech company focused on developing repurposed small molecules based treatments to prevent and treat neurodegenerative dementia of all types. …See details»
medilabo RFP, Inc.:Company Profile & Technical …
Http://medilaborfp.com medilabo RFP, Inc. is a company that provides Botanical drug, Herb and more. medilabo RFP, Inc. is headquartered in Japan Kyoto-fu. medilabo RFP, Inc. was …See details»
株式会社メディラボRFP | InfoBase
「ML 1808」は、ハンセン病の治療薬リファンピシンをベースとした点鼻薬で、アミロイドβ及びタウオリゴマー形成を阻害するのが特徴です。See details»
メディラボRFP の企業情報 - バフェット・コード
株式会社メディラボRFPは、京都に本社を置く会社で、アルツハイマー病の予防薬「ML1808」の開発を行っています。 この会社の目標は、認知症に苦しむ人々の生活の質を維持し、回 …See details»
EN - Addex therapeutics
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known …See details»
メディラボRFP - STARTUP DB｜スタートアップデータベース
アルツハイマー病発症予防点鼻薬を開発・販売する大阪市立大学発スタートアップ。See details»
Home - Appili Therapeutics
A novel topical antiparasitic product to treat disfiguring skin infections around the world. Appili Therapeutics is a people-focused biopharmaceutical company focused on tackling the serious …See details»
medilabo RFP, Inc.:Company Profile & Technical …
Http://medilaborfp.com/ medilabo RFP is a company that provides Botanical drug, Herb and more. medilabo RFP is headquartered in Japan Kyoto. medilabo RFP was founded in 2018. …See details»
Lumos Pharma Homepage
Lumos Pharma is a clinical stage, biopharmaceutical company developing therapeutics for rare diseases. Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in …See details»
株式会社メディラボRFP - スピーダ スタートアップ ...
Feb 21, 2023 · 「ML 1808」は、ハンセン病の治療薬リファンピシンをベースとした点鼻薬で、アミロイドβ及びタウオリゴマー形成を阻害するのが特徴。See details»
HOME - OBI Pharma 台灣浩鼎
Start in Taiwan, Expand Globally, Develop into an International Brand. OBI operates with an excellent management team and efficient business model to create an international Taiwan …See details»
Lumosa Therapeutics | Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs.See details»